Cytiva and Pall to spend $1.5bn on manufacturing capacity …
WEBJul 27, 2021 · Cytiva and Pall Corporation, both subsidiaries of Danaher Corporation, have announced they are to invest US$1.5bn to expand manufacturing capacity across 13 sites globally. The investment will include the doubling of capacity in multiple site locations as well as two new sites: one in the UK and one in the US.
Building a biotech hub: Switzerland focuses on mRNA, CGT and …
WEBSep 8, 2021 · There are 314 biotech companies in Switzerland: broken down into 251 developers and 63 suppliers. Swiss life science exports were valued at CHF 99.1bn ($108bn USD) in 2020 and accounted for 44% of total exports. The sector has grown by a factor of 4.5 since 2000, when life sciences accounted for 17% of …
GE Healthcare Life Sciences completes transition into Cytiva
WEBApr 1, 2020 · Now, with the deal complete, GE Healthcare Life Sciences has emerged at the other side rebranded as Cytiva. The company will retain the same staff, which means that it will have 7,000 employees and possess operations in 40 countries, becoming part of Danaher Corporation Life Sciences platform. CEO and president of Cytiva, Emmanuel Ligner, spoke ...
Pharma and biopharma outsourcing strategies need to use an …
WEBOct 26, 2022 · But a new CPhI report on 'The Future of Outsourcing' advises against this approach. “Traditionally, outsourcing strategies were designed to help secure next stage funding, but many biotechs and small pharma companies are now entering development with more robust cash flows and the ability to plan further downstream," "This opens the …
US pharma hubs: The rising stars to watch
WEBMay 4, 2022 · US pharma hubs: The rising stars to watch. CPhI North America 2022 host city Philadelphia is set to become one of the world’s biggest cell and gene therapy manufacturing hubs. But it’s just one of many centers of innovation that are helping drive the US pharma and biopharma industry. The big four – San Diego, Philadelphia, San Francisco ...
Touchlight set to break ground on world’s highest-capacity DNA ...
WEBOct 18, 2021 · The facility will house 11 new DNA production suites, bringing the total on site to 15 and more than tripling Touchlight’s London-based DNA manufacturing capacity. Once operational in 2022, the biotech said the site will have the capacity to manufacture up to 1kg of GMP DNA per month. That will be more than any other single site worldwide, it ...
Legend Biotech and Janssen establish Belgium cell therapy site
WEBJun 28, 2021 · The Belgian site will be created through the joint investment of Legend Biotech and Janssen, providing the partners additional capacity as they prepare for commercial roll-out of cilta-cel (ciltacabtagene autoleucel). February this year saw the European Medicines Agency (EMA) provide their investigational CAR-T …
AstraZeneca opens new advanced therapeutics R&D facility in …
WEBNov 23, 2021 · News and analysis on the clinical development and manufacture of large molecule drugs. AstraZeneca has built a new R&D facility - The Discovery Centre (DISC) - in Cambridge in the UK. The pharma giant said the new £1bn (US$1.3bn) research and development center will include advanced robotics, high-throughput screening and AI …
Adcendo inks $1 billion deal for global ADC rights
WEBAug 22, 2024 · Adcendo and Multitude target cancer resistance to ADCs in $1BN deal. As antibody-drug conjugates (ADCs) continue to heat up in the industry, Adcendo of Denmark has gained the global rights from Multitude Therapeutics to develop the Chinese company’s ADC for the treatment of cancer outside of the Greater China region.
Sanofi to acquire Translate Bio to develop mRNA tech across …
WEBAug 3, 2021 · Sanofi will acquire clinical-stage mRNA therapeutics company Translate Bio for $3.2bn. Sanofi has partnered with Translate Bio since 2018 on mRNA vaccines; most recently with a COVID-19 vaccine candidate. Coming on the back of its announcement to build an mRNA Center of Excellence, Sanofi says the acquisition will help accelerate development of ...